Home Analyst Ratings

Analyst Ratings

7 days popular

Analyst Downgrades – NYSE:ORA – Ormat Technologies (NYSE:ORA) Stock Gets Downgraded...

ME Staff - May 14, 2018

Analyst Upgrades – CVS Health (NYSE:CVS) Stock Gets Upgraded By Needham...

ME Staff - January 30, 2018

Analyst Activity – SunTrust Banks Raises Its Price Target On NYSE:BABA...

ME Staff - May 7, 2018

Analyst Downgrades – NASDAQ:MHLD – Maiden (NASDAQ:MHLD) Stock Gets Downgraded By...

ME Staff - May 15, 2018

Analyst Upgrades – NYSE:AIG – American International Group (NYSE:AIG) Stock Gets...

ME Staff - May 10, 2018

Analyst Downgrades – NASDAQ:AOSL – Alpha & Omega Semiconductor (NASDAQ:AOSL) Stock...

ME Staff - May 14, 2018

Analyst Upgrades – NASDAQ:BIDU – Baidu (NASDAQ:BIDU) Stock Gets Upgraded By...

ME Staff - May 11, 2018

Analyst Activity – JPMorgan Chase & Co. Raises Its Price Target...

ME Staff - March 28, 2018

Analyst Activity – Credit Suisse Group Initiates Coverage On NASDAQ:BIDU –...

ME Staff - April 23, 2018

Analyst Downgrades – MSC Industrial Direct (NYSE:MSM) Stock Gets Downgraded By...

ME Staff - March 16, 2018

1 234...1,522 Page 3 of 1,522

/* */

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

June 27, 2022

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

June 20, 2022

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

June 6, 2022

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Analyst Ratings

Analyst Downgrades – NYSE:ORA – Ormat Technologies (NYSE:ORA) Stock Gets Downgraded...

Analyst Upgrades – CVS Health (NYSE:CVS) Stock Gets Upgraded By Needham...

Analyst Activity – SunTrust Banks Raises Its Price Target On NYSE:BABA...

Analyst Downgrades – NASDAQ:MHLD – Maiden (NASDAQ:MHLD) Stock Gets Downgraded By...

Analyst Upgrades – NYSE:AIG – American International Group (NYSE:AIG) Stock Gets...

Analyst Downgrades – NASDAQ:AOSL – Alpha & Omega Semiconductor (NASDAQ:AOSL) Stock...

Analyst Upgrades – NASDAQ:BIDU – Baidu (NASDAQ:BIDU) Stock Gets Upgraded By...

Analyst Activity – JPMorgan Chase & Co. Raises Its Price Target...

Analyst Activity – Credit Suisse Group Initiates Coverage On NASDAQ:BIDU –...

Analyst Downgrades – MSC Industrial Direct (NYSE:MSM) Stock Gets Downgraded By...

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY